About this Journal Submit a Manuscript Table of Contents
Mediators of Inflammation
Volume 2013 (2013), Article ID 321460, 11 pages
http://dx.doi.org/10.1155/2013/321460
Research Article

Sildenafil (Viagra) Protective Effects on Neuroinflammation: The Role of iNOS/NO System in an Inflammatory Demyelination Model

1Departamento de Histologia e Embriologia, Instituto de Biologia, Universidade Estadual de Campinas (UNICAMP), Rua Monteiro Lobato 255, 13083-862 Campinas, SP, Brazil
2Laboratório de Ultraestrutura, Centro de Pesquisas Aggeu Magalhães, Fundação Oswaldo Cruz, Av. Professor Moraes Rego, s/n, Cidade Universitária, 50670-420 Recife, PE, Brazil

Received 27 March 2013; Revised 12 June 2013; Accepted 13 June 2013

Academic Editor: Geeta Ramesh

Copyright © 2013 Catarina Raposo et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. Nathan and Q.-W. Xie, “Nitric oxide synthases: roles, tolls, and controls,” Cell, vol. 78, no. 6, pp. 915–918, 1994. View at Publisher · View at Google Scholar · View at Scopus
  2. C. Nathan and Q.-W. Xie, “Regulation of biosynthesis of nitric oxide,” Journal of Biological Chemistry, vol. 269, no. 19, pp. 13725–13728, 1994. View at Scopus
  3. A. C. Palmer, I. M. Calder, and J. T. Hughes, “Spinal cord degeneration in divers,” The Lancet, vol. 2, no. 8572, pp. 1365–1366, 1987. View at Scopus
  4. G. Garthwaite and J. Garthwaite, “Cyclic GMP and cell death in rat cerebellar slices,” Neuroscience, vol. 26, no. 1, pp. 321–326, 1988. View at Scopus
  5. R. G. Knowles, M. Palacios, R. M. Palmer, and S. Moncada, “Formation of nitric oxide from L-arginine in the central nervous system: a transduction mechanism for stimulation of the soluble guanylate cyclase,” Proceedings of the National Academy of Sciences of the United States of America, vol. 86, no. 13, pp. 5159–5162, 1989. View at Scopus
  6. J. B. Hibbs Jr., R. R. Taintor, Z. Vavrin, and E. M. Rachlin, “Nitric oxide: a cytotoxic activated macrophage effector molecule,” Biochemical and Biophysical Research Communications, vol. 157, no. 1, pp. 87–94, 1988. View at Scopus
  7. D. J. Stuehr and C. F. Nathan, “Nitric oxide: a macrophage product responsible for cytostasis and respiratory inhibition in tumor target cells,” Journal of Experimental Medicine, vol. 169, no. 5, pp. 1543–1555, 1989. View at Scopus
  8. J. V. Esplugues, “NO as a signalling molecule in the nervous system,” British Journal of Pharmacology, vol. 135, no. 5, pp. 1079–1095, 2002. View at Scopus
  9. L. Meda, M. A. Cassatella, G. I. Szendrei et al., “Activation of microglial cells by β-amyloid protein and interferon-γ,” Nature, vol. 374, no. 6523, pp. 647–650, 1995. View at Scopus
  10. J. Prickaerts, W. C. G. Van Staveren, A. Şik et al., “Effects of two selective phosphodiesterase type 5 inhibitors, sildenafil and vardenafil, on object recognition memory and hippocampal cyclic GMP levels in the rat,” Neuroscience, vol. 113, no. 2, pp. 351–361, 2002. View at Publisher · View at Google Scholar · View at Scopus
  11. E. G. McGeer and P. L. McGeer, “The role of anti-inflammatory agents in Parkinson's disease,” CNS Drugs, vol. 21, no. 10, pp. 789–797, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. G. A. Rosenberg, “Neurological diseases in relation to the blood-brain barrier,” Journal of Cerebral Blood Flow & Metabolism, vol. 32, pp. 1139–1151, 2012.
  13. D. O. Willenborg, M. Staykova, S. Fordham, N. O'Brien, and D. Linares, “The contribution of nitric oxide and interferon gamma to the regulation of the neuro-inflammation in experimental autoimmune encephalomyelitis,” Journal of Neuroimmunology, vol. 191, no. 1-2, pp. 16–25, 2007. View at Publisher · View at Google Scholar · View at Scopus
  14. U. C. Sahrbacher, F. Lechner, H. P. Eugster, K. Frei, H. Lassmann, and A. Fontana, “Mice with an inactivation of the inducible nitric oxide synthase gene are susceptible to experimental autoimmune encephalomyelitis,” European Journal of Immunology, vol. 28, no. 4, pp. 1332–1338, 1998. View at Scopus
  15. H. A. Arnett, R. P. Hellendall, G. K. Matsushima et al., “The protective role of nitric oxide in a neurotoxicant-induced demyelinating model,” Journal of Immunology, vol. 168, no. 1, pp. 427–433, 2002. View at Scopus
  16. A. T. Bender and J. A. Beavo, “Specific localized expression of cGMP PDEs in Purkinje neurons and macrophages,” Neurochemistry International, vol. 45, no. 6, pp. 853–857, 2004. View at Publisher · View at Google Scholar · View at Scopus
  17. J. Schlossmann and F. Hofmann, “cGMP-dependent protein kinases in drug discovery,” Drug Discovery Today, vol. 10, no. 9, pp. 627–634, 2005. View at Publisher · View at Google Scholar · View at Scopus
  18. M. Kipp, T. Clarner, S. Gingele et al., “Brain lipid binding protein (FABP7) as modulator of astrocyte function,” Physiological Research, vol. 60, supplement 1, pp. S49–S60, 2011. View at Scopus
  19. A. Palmeri, L. Privitera, S. Giunta, C. Loreto, and D. Puzzo, “Inhibition of phosphodiesterase-5 rescues age-related impairment of synaptic plasticity and memory,” Behavioural Brain Research, vol. 240, pp. 11–20, 2013.
  20. L. Zhang, W. Yu, I. Schroedter, J. Kong, and M. Vrontakis, “Galanin transgenic mice with elevated circulating galanin levels alleviate demyelination in a cuprizone-induced ms mouse model,” PLoS ONE, vol. 7, no. 3, article e33901, 2012. View at Publisher · View at Google Scholar · View at Scopus
  21. P. Pifarre, J. Prado, M. A. Baltrons et al., “Sildenafil (Viagra) ameliorates clinical symptoms and neuropathology in a mouse model of multiple sclerosis,” Acta Neuropathologica, vol. 121, no. 4, pp. 499–508, 2011. View at Publisher · View at Google Scholar · View at Scopus
  22. A. K. S. Nunes, C. Rapôso, R. L. Luna, M. A. Cruz-Höfling, and C. A. Peixoto, “Sildenafil (Viagra) down regulates cytokines and prevents demyelination in a cuprizone-induced MS mouse model,” Cytokine, vol. 60, pp. 540–551, 2012.
  23. L. Zhao, N. A. Mason, J. W. Strange, H. Walker, and M. R. Wilkins, “Beneficial effects of phosphodiesterase 5 inhibition in pulmonary hypertension are influenced by natriuretic peptide activity,” Circulation, vol. 107, no. 2, pp. 234–237, 2003. View at Publisher · View at Google Scholar · View at Scopus
  24. K. L. A. Saraiva, A. K. Silva, M. I. Wanderley, A. A. De Araújo, J. R. De Souza, and C. A. Peixoto, “Chronic treatment with sildenafil stimulates Leydig cell and testosterone secretion,” International Journal of Experimental Pathology, vol. 90, no. 4, pp. 454–462, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. D. Moharregh-Khiabani, A. Blank, T. Skripuletz et al., “Effects of fumaric acids on cuprizone induced central nervous system de- and remyelination in the mouse,” PLoS ONE, vol. 5, no. 7, article e11769, 2010. View at Publisher · View at Google Scholar · View at Scopus
  26. Z. Gao and S. E. Tsirka, “Animal Models of MS reveal multiple roles of microglia in disease pathogenesis,” Neurology Research International, vol. 2011, Article ID 383087, 9 pages, 2011. View at Publisher · View at Google Scholar
  27. L. Silvestroff, S. Bartucci, J. Pasquini, and P. Franco, “Cuprizone-induced demyelination in the rat cerebral cortex and thyroid hormone effects on cortical remyelination,” Experimental Neurology, vol. 235, no. 1, pp. 357–367, 2012. View at Publisher · View at Google Scholar · View at Scopus
  28. G. Riccitelli, M. A. Rocca, E. Pagani, et al., “Mapping regional grey and white matter atrophy in relapsing-remitting multiple sclerosis,” Multiple Sclerosis, vol. 18, no. 7, pp. 1027–1037, 2012. View at Publisher · View at Google Scholar
  29. S. D. Shields, X. Cheng, A. Gasser et al., “A channelopathy contributes to cerebellar dysfunction in a model of multiple sclerosis,” Annals of Neurology, vol. 71, no. 2, pp. 186–194, 2012. View at Publisher · View at Google Scholar · View at Scopus
  30. C. Bernardini, F. Greco, A. Zannoni, M. L. Bacci, E. Seren, and M. Forni, “Differential expression of nitric oxide synthases in porcine aortic endothelial cells during LPS-induced apoptosis,” The Journal of Inflammation, vol. 9, p. 47, 2012.
  31. W.-L. Chang, C.-H. Chung, Y.-C. Wu, and M.-J. Su, “The vascular and cardioprotective effects of liriodenine in ischemia-reperfusion injury via NO-dependent pathway,” Nitric Oxide, vol. 11, no. 4, pp. 307–315, 2004. View at Publisher · View at Google Scholar · View at Scopus
  32. D. Pérez-Sala, E. Cernuda-Morollón, M. Díaz-Cazorla, F. Rodríguez-Pascual, and S. Lamas, “Posttranscriptional regulation of human iNOS by the NO/cGMP pathway,” American Journal of Physiology, vol. 280, pp. 466–473, 2001.
  33. P. K. Datta, S. Dhupar, and E. A. Lianos, “Regulatory effects of inducible nitric oxide synthase on cyclooxygenase-2 and heme oxygenase-1 expression in experimental glomerulonephritis,” Nephrology Dialysis Transplantation, vol. 21, no. 1, pp. 51–57, 2006. View at Publisher · View at Google Scholar · View at Scopus
  34. A. A. Beg and D. Baltimore, “An essential role for NF-κB in preventing TNF-α-induced cell death,” Science, vol. 274, no. 5288, pp. 782–784, 1996. View at Publisher · View at Google Scholar · View at Scopus
  35. R. S. Chanthaphavong, P. A. Loughran, T. Y. Lee, M. J. Scott, and T. R. Billiar, “A role for cGMP in inducible nitric-oxide synthase (iNOS)-induced tumor necrosis factor (TNF) α-converting enzyme (TACE/ADAM17) activation, translocation, and TNF receptor 1 (TNFR1) shedding in hepatocytes,” Journal of Biological Chemistry, vol. 287, pp. 35887–35898, 2012.
  36. A. A. Beg and D. Baltimore, “An essential role for NF-κB in preventing TNF-α-induced cell death,” Science, vol. 274, no. 5288, pp. 782–784, 1996. View at Publisher · View at Google Scholar · View at Scopus
  37. K. Bénardais, A. Kotsiari, J. Skuljec, et al., “Cuprizone [bis(cyclohexylidenehydrazide)] is selectively toxic for mature oligodendrocytes,” Neurotoxicity Research, vol. 24, no. 2, pp. 244–250, 2013.
  38. J. A. Benjamins and L. Nedelkoska, “Cyclic GMP-dependent pathways protect differentiated oligodendrocytes from multiple types of injury,” Neurochemical Research, vol. 32, no. 2, pp. 321–329, 2007. View at Publisher · View at Google Scholar · View at Scopus